STOCK TITAN

Carlsmed (NASDAQ: CARL) director receives 13,698 RSUs equity award

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
4

Rhea-AI Filing Summary

CARLSMED, INC. director Philip M. Young received a grant of 13,698 restricted stock units (RSUs) of Common Stock on June 3, 2026. Each RSU converts into one share when it vests.

The RSUs vest in full on the earlier of the day before Carlsmed’s 2027 annual stockholder meeting or June 3, 2027, as long as Young continues serving on the board through that date. Following this award, he holds 31,031 shares directly, 53,333 shares indirectly through PMY Partners L.P., where he is sole general partner with voting and dispositive power, and additional shares through the Young Family Trust, where he is a trustee with similar authority.

Positive

  • None.

Negative

  • None.
Insider YOUNG PHILIP M
Role null
Type Security Shares Price Value
Grant/Award Common Stock 13,698 $0.00 --
holding Common Stock -- -- --
holding Common Stock -- -- --
Holdings After Transaction: Common Stock — 31,031 shares (Direct, null); Common Stock — 35,566 shares (Indirect, See footnotes)
Footnotes (1)
  1. Constitutes an award of restricted stock units ("RSUs") for which the Reporting Person is entitled to receive one (1) share of Common Stock for each RSU upon vesting. The RSUs will vest in full on the earlier of (i) the day before the Issuer's 2027 annual meeting of stockholders or (ii) June 3, 2027, subject, in all cases, to the Reporting Person's continued service as a member of the Board of Directors through such vesting date. Stock held by PMY Partners LP. Reporting Person is the sole general partner of PMY Partners L.P. and has voting and dispositive power over the stock held by PMY Partners L.P. Includes shares of the Issuer's common stock held by the Young Family Trust dtd 04/13/1998 Nancy Halsey Young & Philip Young, Trustees. Reporting Person is a trustee of the Trust and has voting and dispositive power over the stock held by the Trust.
RSU grant size 13,698 RSUs Award of restricted stock units on June 3, 2026
Direct holdings after grant 31,031 shares Common Stock held directly following the RSU award
PMY Partners L.P. holdings 53,333 shares Common Stock held indirectly via PMY Partners L.P.
Additional indirect trust holdings 35,566 shares Common Stock held indirectly via Young Family Trust
RSU vesting date Earlier of day before 2027 annual meeting or June 3, 2027 Single vesting date contingent on continued board service
restricted stock units ("RSUs") financial
"Constitutes an award of restricted stock units ("RSUs") for which the Reporting Person is entitled to receive one (1) share of Common Stock"
Restricted stock units (RSUs) are a company promise to give an employee shares of stock (or cash equivalent) in the future, but only after certain conditions—usually staying with the company for a set time or hitting performance goals—are met. Investors watch RSUs because when they vest they increase the number of shares outstanding and can lead insiders to sell shares, affecting share price, company dilution and the true cost of employee pay.
voting and dispositive power financial
"has voting and dispositive power over the stock held by PMY Partners L.P."
general partner financial
"Reporting Person is the sole general partner of PMY Partners L.P."
A general partner is the person or firm that runs an investment partnership and legally represents it — they make the day-to-day decisions, choose which assets to buy or sell, and are responsible for the partnership’s obligations. Investors care because the general partner’s judgment, risk-taking and fee and profit-sharing arrangements determine both the potential returns and the level of exposure to losses; think of the GP as the ship’s captain whose skill and honesty shape the voyage’s outcome.
Trust financial
"Includes shares of the Issuer's common stock held by the Young Family Trust dtd 04/13/1998"
A trust is a legal setup in which one party (the trustee) holds and manages assets—like cash, stocks or property—on behalf of other people (beneficiaries) according to instructions from the person who created it (the grantor). Think of it as a locked box with a keyholder who must follow written rules; for investors it matters because trusts influence who controls and benefits from assets, affect taxes and succession, and can change how quickly or transparently shares are bought, sold or voted.
See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Learn about SEC filing dates
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
YOUNG PHILIP M

(Last)(First)(Middle)
C/O CARLSMED, INC.
1800 ASTON AVE., SUITE 100

(Street)
CARLSBAD CALIFORNIA 92008

(City)(State)(Zip)

UNITED STATES

(Country)
2. Issuer Name and Ticker or Trading Symbol
CARLSMED, INC. [ CARL ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
XDirector10% Owner
Officer (give title below)Other (specify below)
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
06/03/2026
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Common Stock06/03/2026A13,698(1)A$031,031D
Common Stock35,566ISee footnotes(2)(3)
Common Stock53,333ISee footnotes(4)(5)
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Explanation of Responses:
1. Constitutes an award of restricted stock units ("RSUs") for which the Reporting Person is entitled to receive one (1) share of Common Stock for each RSU upon vesting. The RSUs will vest in full on the earlier of (i) the day before the Issuer's 2027 annual meeting of stockholders or (ii) June 3, 2027, subject, in all cases, to the Reporting Person's continued service as a member of the Board of Directors through such vesting date.
2. Stock held by PMY Partners LP.
3. Reporting Person is the sole general partner of PMY Partners L.P. and has voting and dispositive power over the stock held by PMY Partners L.P.
4. Includes shares of the Issuer's common stock held by the Young Family Trust dtd 04/13/1998 Nancy Halsey Young & Philip Young, Trustees.
5. Reporting Person is a trustee of the Trust and has voting and dispositive power over the stock held by the Trust.
/s/ Leonard Greenstein, as attorney-in-fact for Philip Young06/22/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What did Carlsmed (CARL) director Philip M. Young receive in this Form 4?

Philip M. Young received a grant of 13,698 restricted stock units (RSUs) of Carlsmed Common Stock. Each RSU represents the right to receive one share upon vesting, providing equity-based compensation tied to his continued board service.

When do Philip M. Young’s 13,698 RSUs in Carlsmed (CARL) vest?

The 13,698 RSUs vest in full on the earlier of the day before Carlsmed’s 2027 annual stockholder meeting or June 3, 2027. Vesting is contingent on Young’s continued service on the Board of Directors through that date.

How many Carlsmed (CARL) shares does Philip M. Young hold directly after this award?

After the RSU grant, Philip M. Young holds 31,031 shares of Carlsmed Common Stock directly. This direct position is in addition to his indirect holdings through PMY Partners L.P. and the Young Family Trust, over which he has voting and dispositive power.

What indirect Carlsmed (CARL) holdings are associated with Philip M. Young?

Indirect holdings include shares held by PMY Partners L.P. and by the Young Family Trust dated April 13, 1998. Young is sole general partner of PMY Partners and a trustee of the trust, giving him voting and dispositive power over those shares.

Is the RSU grant to Carlsmed (CARL) director Philip M. Young an open-market purchase?

No, the 13,698-share RSU grant is a compensation-related award, not an open-market purchase. It was reported with transaction code A, indicating a grant, award, or other acquisition rather than a market buy or sell transaction.